The new EU label is broader than in the US, where the FDA approved Xofluza last August for treatment in children aged five years and older and post-exposure prophylaxis in those aged over 12.
Constance Mayer (1775-1821) was one of a generation of women artists who took advantage of the new freedoms offered by the French Revolution.